TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32353342

Group type: EXPERIMENTAL
Intervention: Abemaciclib (150 mg orally every 12 hours on days 1-21 of a 21-day cycle), trastuzumab (8 mg/kg on cycle 1 day 1, then 6 mg/kg on day 1 of each subsequent cycle), and fulvestrant (500 mg on days 1, 15, and 29, then once every 4 weeks thereafter)
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Abemaciclib (150 mg orally every 12 hours on days 1-21 of a 21-day cycle) and trastuzumab (8 mg/kg on cycle 1 day 1, then 6 mg/kg on day 1 of each subsequent cycle)
Number of subjects: 237

Group type: COMPARATOR
Intervention: Standard-of-care chemotherapy plus trastuzumab
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Abemaciclib, fulvestrant, and trastuzumab
Number of subjects: 237
Study: 32250132

Group type: EXPERIMENTAL
Intervention: Social Cognition Training Program (SCTP), 12 sessions
Number of subjects: 299

Group type: COMPARATOR
Intervention: Neurocognitive training
Number of subjects: 299
Study: 32997761

Group type: EXPERIMENTAL
Intervention: Full Debridement (FD)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Partial Debridement (PD)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group (debridement simulation)
Number of subjects: 300
Study: 33781616

Group type: EXPERIMENTAL
Intervention: Mendelian randomization using genetic variants as instrumental variables
Number of subjects: 0
Study: 32661681

Group type: EXPERIMENTAL
Intervention: Hesperidin-enriched orange juice (EOJ)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Orange juice (OJ)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Control drink
Number of subjects: 159
Study: 35729605

Group type: EXPERIMENTAL
Intervention: Voice-activated delivery of cognitive behavioral therapy for insomnia (CBT-I) components using a smart speaker device for 6 weeks.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sleep education control using a website with basic information about CBT-I, sleep, and breast cancer survivorship.
Number of subjects: 100
Study: 32069319

Group type: EXPERIMENTAL
Intervention: Upper-body muscle strength at 16th week
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Maternal flexibility at 16th week
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Maternal cardiorespiratory fitness (CRF) at 16th week
Number of subjects: 159

Group type: COMPARATOR
Intervention: Overall physical fitness at 16th and 34th weeks
Number of subjects: 159
Study: 35392766

Group type: EXPERIMENTAL
Intervention: Inhaling 800 µg salbutamol
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 34167597

Group type: EXPERIMENTAL
Intervention: Dietary Quality Index-International (DQI-I)
Number of subjects: 726

Group type: EXPERIMENTAL
Intervention: Dietary Phytochemical Index (DPI)
Number of subjects: 726

Group type: EXPERIMENTAL
Intervention: T-allele carriers with highest level of PGF2α
Number of subjects: 726

Group type: EXPERIMENTAL
Intervention: CCs in the second tertile of DPI
Number of subjects: 726
Study: 32017817

Group type: EXPERIMENTAL
Intervention: Standard rehabilitation program (Gr. 2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No structured rehabilitation (Gr. 1)
Number of subjects: 0
Study: 35578268

Group type: EXPERIMENTAL
Intervention: Folic acid supplementation (400 µg/day)
Number of subjects: 0
Study: 32493276

Group type: EXPERIMENTAL
Intervention: Lidocaine 2% (intravenous bolus 1.5 mg/kg followed by an infusion of 2 mg/kg/h)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Normal saline (equal volume to lidocaine)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Lidocaine 2%
Number of subjects: 64

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 64
Study: 34255321

Group type: EXPERIMENTAL
Intervention: Tonic stimulation
Number of subjects: 10

Group type: COMPARATOR
Intervention: BurstDR stimulation
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 10
Study: 33098953

Group type: EXPERIMENTAL
Intervention: Losartan treatment
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Baseline aortic root measurement
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Aortic root growth after 2 years
Number of subjects: 66
Study: 36428062

Group type: EXPERIMENTAL
Intervention: Online HOPE intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study: 34452669

Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation exercise
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Body functionality writing exercise
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Four-session online intervention
Number of subjects: 255

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 255
Study: 33044421

Group type: EXPERIMENTAL
Intervention: PalliActive Caregivers intervention
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Experimental group
Number of subjects: 80
Study: 34285282

Group type: EXPERIMENTAL
Intervention: G-PUR 2.0 g
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: G-PUR 2 * 2.0 g
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 33052122

Group type: EXPERIMENTAL
Intervention: ImTeCHO intervention
Number of subjects: 5754

Group type: COMPARATOR
Intervention: Routine maternal, neonatal, and child health care programs
Number of subjects: 5754
Study: 35098782

Group type: EXPERIMENTAL
Intervention: Radial flow oxygenator
Number of subjects: 52

Group type: COMPARATOR
Intervention: Axial flow oxygenator
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 52
Study: 32732354

Group type: EXPERIMENTAL
Intervention: Imetelstat
Number of subjects: 50
Study: 36098028

Group type: EXPERIMENTAL
Intervention: Integrated multidomain intervention (16 2-hour sessions per year including physical exercise, cognitive training, nutrition and disease education, plus individualized treatment by specialists)
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: Integrated multidomain intervention
Number of subjects: 398

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 398
Study: 34057659

Group type: EXPERIMENTAL
Intervention: U=U messaging
Number of subjects: 1048

Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 1048
Study: 33378495

Group type: EXPERIMENTAL
Intervention: 400 g of intrusive force
Number of subjects: 22

Group type: COMPARATOR
Intervention: 200 g of intrusive force
Number of subjects: 22
Study: 35841908

Group type: EXPERIMENTAL
Intervention: Rituximab (1000 mg followed by 500 mg every 6 months)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Dimethyl fumarate (240 mg twice daily)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 200

Group type: COMPARATOR
Intervention: Dimethyl fumarate
Number of subjects: 200
Study: 33910364

Group type: EXPERIMENTAL
Intervention: Exo group (mechanized device - Armeo Spring)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Control group (stretching plus basic active exercises)
Number of subjects: 215
Study: 32339745

Group type: EXPERIMENTAL
Intervention: O-arm
Number of subjects: 58

Group type: COMPARATOR
Intervention: C-arm
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Bilateral TAS fixation
Number of subjects: 58
Study: 36153457

Group type: EXPERIMENTAL
Intervention: Pricking and cupping therapy + Chinese herbal wet compress + basic treatment
Number of subjects: 232

Group type: COMPARATOR
Intervention: Pricking and cupping + basic treatment
Number of subjects: 232

Group type: COMPARATOR
Intervention: Chinese herbal wet compress + basic treatment
Number of subjects: 232

Group type: COMPARATOR
Intervention: Basic treatment
Number of subjects: 232
Study: 32893826

Group type: EXPERIMENTAL
Intervention: Unintentional injuries prevalence
Number of subjects: 650

Group type: EXPERIMENTAL
Intervention: Male children
Number of subjects: 650

Group type: EXPERIMENTAL
Intervention: Age increase from 2 to 5 years
Number of subjects: 650

Group type: EXPERIMENTAL
Intervention: Children of working mothers
Number of subjects: 650

Group type: EXPERIMENTAL
Intervention: Families with more than 3 children
Number of subjects: 650

Group type: EXPERIMENTAL
Intervention: Households without a separate kitchen
Number of subjects: 650

Group type: EXPERIMENTAL
Intervention: Households with inadequate lighting
Number of subjects: 650
Study: 33527413

Group type: EXPERIMENTAL
Intervention: UltraAC (Ultraconservative access cavity preparation)
Number of subjects: 60

Group type: COMPARATOR
Intervention: TradAC (Traditional access cavity preparation)
Number of subjects: 60

Group type: COMPARATOR
Intervention: TradAC
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: UltraAC
Number of subjects: 60
Study: 33099541

Group type: EXPERIMENTAL
Intervention: Age at menarche
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Childhood body size (plumper than average at age 10)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tanning habits (very tanned or moderately tanned)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multivariable MR analysis for age at menarche
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MR analysis for ease of tanning
Number of subjects: 0

Group type: COMPARATOR
Intervention: MR‐EWAS approach
Number of subjects: 0
Study: 35853695

Group type: EXPERIMENTAL
Intervention: Composite endpoint using joint frailty modeling in response-adaptive randomization.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Balanced randomized design.
Number of subjects: 0
Study: 33626877

Group type: EXPERIMENTAL
Intervention: Full dose of protamine (1 mg per mg heparin used)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Lower dose of protamine (0.8 mg per mg heparin used)
Number of subjects: 90
Study: 32537643

Group type: EXPERIMENTAL
Intervention: Modestly lower carbohydrate diet (MLC, ∼135 g/d carbohydrate)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Routine care (RC, ∼200 g/d carbohydrate)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Modestly lower carbohydrate diet (MLC)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Routine care (RC)
Number of subjects: 46
Study: 34702395

Group type: EXPERIMENTAL
Intervention: Total annulus excision tympanoplasty (group B)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Conventional tympanoplasty (group A)
Number of subjects: 56
Study: 32897368

Group type: EXPERIMENTAL
Intervention: Suptavumab (1 dose)
Number of subjects: 1154

Group type: EXPERIMENTAL
Intervention: Suptavumab (2 doses)
Number of subjects: 1154

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1154
Study: 35717999

Group type: EXPERIMENTAL
Intervention: Statin treatment
Number of subjects: 0
Study: 32856379

Group type: EXPERIMENTAL
Intervention: Daily life activities simulation
Number of subjects: 119

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 119
Study: 33481114

Group type: EXPERIMENTAL
Intervention: Joy Luck Academy program (weekly education and peer-mentor support sessions)
Number of subjects: 129
Study: 35909334

Group type: COMPARATOR
Intervention: Iron–folic acid (IFA) capsule (control)
Number of subjects: 1391

Group type: COMPARATOR
Intervention: Multiple micronutrient (MMN) capsule of 18 micronutrients (second control)
Number of subjects: 1391

Group type: EXPERIMENTAL
Intervention: Small‐quantity lipid‐based nutrient supplements (SQ‐LNS)
Number of subjects: 1391
Study: 34216630

Group type: EXPERIMENTAL
Intervention: Post-traumatic stress disorder in parents
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Post-traumatic stress symptom severity
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Post-traumatic stress symptom clusters (avoidance, arousal, re-experiencing)
Number of subjects: 153
Study: 34158672

Group type: EXPERIMENTAL
Intervention: Mucolytic solution (100 mL water + 400 mg N-acetylcysteine + 20 mg simethicone)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Control group (without the solution)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Control group (100 mL pure water)
Number of subjects: 134
Study: 33908285

Group type: EXPERIMENTAL
Intervention: Hyperglycemic-hyperinsulinemia
Number of subjects: 0
Study: 34491648

Group type: EXPERIMENTAL
Intervention: Acupuncture plus medication (horizontal penetration needling combined with rizatriptan monobenzoate tablets)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Acupuncture (horizontal penetration needling)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Western medication (rizatriptan monobenzoate tablets 10 mg)
Number of subjects: 99
Study: 32293363

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT‐I)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Chronobiological Therapy (CT)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT‐I) + Chronobiological Therapy (CT)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 120
Study: 34853784

Group type: EXPERIMENTAL
Intervention: Working Memory Training (WMT)
Number of subjects: 64
Study: 32450273

Group type: EXPERIMENTAL
Intervention: Whole-body tilting postural training (WTPT) using a Spine Balance 3D
Number of subjects: 30

Group type: COMPARATOR
Intervention: General postural training (GPT)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Whole-body tilting postural training (WTPT)
Number of subjects: 30
Study: 32247517

Group type: EXPERIMENTAL
Intervention: Parental instrumental feeding
Number of subjects: 534

Group type: EXPERIMENTAL
Intervention: Parental emotional feeding
Number of subjects: 534
Study: 35722977

Group type: EXPERIMENTAL
Intervention: Perilla frutescens seed oil (PO) 1.47 mL daily (0.88 g ALA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Perilla frutescens seed oil (PO) 1.47 mL daily (0.88 g ALA) and Anredera cordifolia leaf powder 1.12 g daily (1.46 mg vitexin and 1.12 mg adenosine)
Number of subjects: 0
Study: 32019524

Group type: EXPERIMENTAL
Intervention: Mindful Leadership course
Number of subjects: 52
Study: 35983524

Group type: EXPERIMENTAL
Intervention: Personalized health management mode based on the Internet mode
Number of subjects: 60
Study: 35362717

Group type: EXPERIMENTAL
Intervention: Vitamin C acid stimulation
Number of subjects: 120

Group type: COMPARATOR
Intervention: Routine swallowing training (Control)
Number of subjects: 120
Study: 35331251

Group type: EXPERIMENTAL
Intervention: Thick Blood Smear (TBS)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ultrasensitive Rapid Diagnostic Test (uRDT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional Rapid Diagnostic Test (cRDT)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Quantitative PCR (qPCR)
Number of subjects: 24
Study: 32653012

Group type: EXPERIMENTAL
Intervention: Protein-only group receiving dairy products to increase protein intake to 1.5 g/kg/day
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Protein + exercise group receiving protein intervention and power training two times a week
Number of subjects: 150

Group type: COMPARATOR
Intervention: Recommendation group continuing as in phase 1
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Protein-only group
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Protein + exercise group
Number of subjects: 150

Group type: COMPARATOR
Intervention: Recommendation group
Number of subjects: 150
Study: 35714276

Group type: EXPERIMENTAL
Intervention: IIV4-W
Number of subjects: 2400

Group type: COMPARATOR
Intervention: TIV1
Number of subjects: 2400

Group type: COMPARATOR
Intervention: TIV2
Number of subjects: 2400
Study: 35239971

Group type: EXPERIMENTAL
Intervention: Dasiglucagon (0.6 mg)
Number of subjects: 170
Study: 32149879

Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Exercise (MICE) for 30 minutes at 50-55% of heart rate reserve (HRR)
Number of subjects: 19

Group type: COMPARATOR
Intervention: High-Intensity Interval Exercise (HIIE) consisting of 10 × 1 minute at 80-85% of HRR and 2 minutes at 40-45% of HRR
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control session
Number of subjects: 19
Study: 35152575

Group type: EXPERIMENTAL
Intervention: Acupoint injection of mecobalamin
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Vitalstim electrical stimulation
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Combination of acupoint injection and Vitalstim electrical stimulation
Number of subjects: 98
Study: 36202733

Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) intervention for 12 weeks
Number of subjects: 43

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 43
Study: 34392865

Group type: EXPERIMENTAL
Intervention: Slide presentation (Group 1; SP‐G)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Video clip (Group 2; V‐G)
Number of subjects: 60
Study: 32071465

Group type: EXPERIMENTAL
Intervention: Ultrasonic subgingival debridement combined with manual root planing
Number of subjects: 23

Group type: COMPARATOR
Intervention: Ultrasonic subgingival debridement
Number of subjects: 23
Study: 35856588

Group type: EXPERIMENTAL
Intervention: Chlorhexidine (di)gluconate lock solution (CHGLS)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 100
Study: 34370327

Group type: EXPERIMENTAL
Intervention: Therapeutic exercise programme (G1)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Therapeutic and aerobic exercise programme (G2)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Aerobic exercise programme (G3)
Number of subjects: 45
Study: 32559644

Group type: EXPERIMENTAL
Intervention: Walking with continuous stochastic perturbations
Number of subjects: 21
Study: 35131967

Group type: EXPERIMENTAL
Intervention: H. pylori positive
Number of subjects: 3001

Group type: EXPERIMENTAL
Intervention: H. pylori negative
Number of subjects: 3001

Group type: EXPERIMENTAL
Intervention: Alcohol consumption
Number of subjects: 3001

Group type: EXPERIMENTAL
Intervention: Coffee consumption
Number of subjects: 3001

Group type: EXPERIMENTAL
Intervention: Onion consumption
Number of subjects: 3001

Group type: EXPERIMENTAL
Intervention: Former smoking
Number of subjects: 3001

Group type: EXPERIMENTAL
Intervention: Pickled product consumption
Number of subjects: 3001

Group type: EXPERIMENTAL
Intervention: Proton pump inhibitor use
Number of subjects: 3001
Study: 34909917

Group type: EXPERIMENTAL
Intervention: Oral pilocarpine (20 mg daily)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 33639559

Group type: EXPERIMENTAL
Intervention: Combination of feedback and modeling
Number of subjects: 32

Group type: COMPARATOR
Intervention: Feedback alone
Number of subjects: 32

Group type: COMPARATOR
Intervention: Modeling alone
Number of subjects: 32
Study: 36121443

Group type: EXPERIMENTAL
Intervention: Housing voucher redeemable in a low-poverty neighborhood plus housing counseling
Number of subjects: 4600

Group type: EXPERIMENTAL
Intervention: Housing voucher without locational restriction
Number of subjects: 4600

Group type: COMPARATOR
Intervention: No voucher (control)
Number of subjects: 4600
Study: 33906609

Group type: COMPARATOR
Intervention: Initial heparin dose of 100 U/kg (Warfarin group)
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Initial heparin dose of 110 U/kg (NOAC group)
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Initial heparin dose of 120 U/kg (NOAC group)
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Initial heparin dose of 130 U/kg (NOAC group)
Number of subjects: 187
Study: 33402626

Group type: EXPERIMENTAL
Intervention: Interactive distraction (ID) with handheld video game (HVG)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Parent-provided distraction (PPD)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Pulse rate in PPD group
Number of subjects: 30

Group type: COMPARATOR
Intervention: Pulse rate
Number of subjects: 30

Group type: COMPARATOR
Intervention: FLACC scores
Number of subjects: 30
Study: 32602755

Group type: EXPERIMENTAL
Intervention: Topical oxymetazoline (OXZ) 1.5% in liposomal base
Number of subjects: 40

Group type: COMPARATOR
Intervention: Topical lipogel (control)
Number of subjects: 40
Study: 33595845

Group type: EXPERIMENTAL
Intervention: Benralizumab 30 mg SC
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 33157937

Group type: EXPERIMENTAL
Intervention: 8-week lifestyle change promotion program
Number of subjects: 180

Group type: COMPARATOR
Intervention: 8-week mindfulness-based cognitive therapy program
Number of subjects: 180

Group type: COMPARATOR
Intervention: Written suggestions for lifestyle changes
Number of subjects: 180
Study: 36122912

Group type: EXPERIMENTAL
Intervention: Four implants
Number of subjects: 50

Group type: COMPARATOR
Intervention: Six implants
Number of subjects: 50
Study: 34444984

Group type: EXPERIMENTAL
Intervention: Social norms-based intervention (RANI Project)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 616063206

Group type: EXPERIMENTAL
Intervention: Patient navigation with legal support and services
Number of subjects: 103

Group type: COMPARATOR
Intervention: Patient navigation without legal support and services
Number of subjects: 103
Study: 36038894

Group type: EXPERIMENTAL
Intervention: eHealth application 'alley' as an adjuvant intervention to TJA
Number of subjects: 400

Group type: COMPARATOR
Intervention: Control group (no access to the app)
Number of subjects: 400
Study: 34508602

Group type: EXPERIMENTAL
Intervention: Remote nurse-led symptom care manager (RN SCM) phone call
Number of subjects: 864

Group type: EXPERIMENTAL
Intervention: Opt-out framing for receiving RN SCM calls
Number of subjects: 864

Group type: EXPERIMENTAL
Intervention: Receiving care at a tertiary care center
Number of subjects: 864

Group type: EXPERIMENTAL
Intervention: Severe pain
Number of subjects: 864
Study: 34764014

Group type: EXPERIMENTAL
Intervention: Acupressure at the BL67 point for 10 minutes daily for two consecutive weeks
Number of subjects: 138

Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Acupressure at the BL67 point
Number of subjects: 138
Study: 32408883

Group type: EXPERIMENTAL
Intervention: Neurally adjusted ventilatory assist (NAVA)
Number of subjects: 78
Study: 36206239

Group type: EXPERIMENTAL
Intervention: Technological visuo-cognitive training (TVT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 40
Study: 32829494

Group type: EXPERIMENTAL
Intervention: Music intervention
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (waiting list)
Number of subjects: 50